LANXESS disinfectant kills Coronavirus SARS-CoV-2 in just 60 seconds


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ disinfectant-kills-coronavirus-sars-cov2-just-60-seconds
Lanxess claims corona free surfaces in 60 seconds

Rely+On Virkon broad spectrum disinfectant, produced by specialty Chemicals Company LANXESS, demonstrates extremely rapid efficacy against the SARS-CoV-2 virus.

This is the finding of a recent study LANXESS commissioned through independent analysis laboratory Microbac Laboratories, Inc. in accordance with the U.S. Environmental Protection Agency (EPA) compliant test methods, for products intended for virucidal hard surface disinfection.

Rely+On Virkon achieved rapid and complete inactivation of the SARS-CoV-2 virus at a dilution ratio of 1:100 in just 60 seconds, and at an economical 1:600 in-use dilution with a 10 minute contact time.

Corresponding efficacy data has to be provided for disinfectants that claim to combat SARS-CoV-2. Microbac is one of the few testing laboratories worldwide that U.S. health authority CDC (Center for Disease Control) has certified to undertake such tests.“Neither a vaccine nor generally approved medications are currently available to us in the fight against the global coronavirus pandemic.So alongside social distancing and hand-washing, disinfection remains a highly important means to help prevent the spread of this life-threatening respiratory illness,” says Anneliese Bischof, Business Director Disinfection at LANXESS. “Right now, good hygiene cleaning and disinfection practices are more important than ever. The fact that Rely+On Virkon inactivates SARS-CoV-2 so quickly will help reassure people that the disinfectant product they are using is both fast and effective in practical use,” underlines Bischof.

Rely+On Virkon is a powder disinfectant concentrate diluted in water for application as a spray on hard surfaces and equipment (non-medical). It can therefore help to reduce the risk of cross-contamination from surfaces, door handles, tables or chairs during disinfection measures at public transport terminals, airports, hospitals, clinics, shopping malls, etc.

The LANXESS Material Protection Products business unit produces a wide range of scientifically based disinfection technologies under the Rely+On and Virkon brand.

LANXESS is a leading specialty chemicals company with sales of EUR 6.8 billion in 2019. The company currently has about 14,300 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Tags : #Sars-Cov-2 #Lanxess #Disinfection #Microbac #CDC #RelyOn #Virkon

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026